Torus Biosystems
PrivateLast Round
Series A
May 26, 2021
Total Funding Raised
$28.8M
Company Overview
Torus Biosystems operates in Healthcare & Life Sciences and is based in Medford, Massachusetts. Its latest recorded funding round was a Series A round in May 2021.
Torus Biosystems is a biotechnology company that develops rapid, point-of-care syndromic diagnostic testing solutions for infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment
Business Model
B2B
Customer Profile
Usage-Based SaaS, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Torus Biosystems Comparables
Compare Torus Biosystems with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| binx health | 81% | |
| QuantuMDx | 80% | |
| Danaher | 76% |
For institutional investors. Book with your work email.
Torus Biosystems Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 26, 2021 | ||||
| Grant | Jan 13, 2021 | ||||
| Convertible Debt | Dec 29, 2020 | ||||
| Seed | Feb 7, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Torus Biosystems Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Northpond Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 26, 2021
$25M round led by Northpond Ventures.
- Jan 13, 2021
$300K awarded by NIH RADx
For institutional investors. Book with your work email.
Torus Biosystems Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Torus Biosystems's valuation, stock price, and market status.
Is Torus Biosystems a public or private company?
Torus Biosystems is a private company.
What is the current stock price of Torus Biosystems?
Torus Biosystems is a private company, so its shares have no public market price. Caplight tracks Torus Biosystems's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Torus Biosystems worth (valuation)?
Valuation information for Torus Biosystems is not publicly available.
Can I buy Torus Biosystems stock?
Torus Biosystems shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Torus Biosystems's last funding round?
Torus Biosystems's most recent funding round was Series A on May 26, 2021.
Who are the main investors in Torus Biosystems?
Key investors in Torus Biosystems include Northpond Ventures.
Will Torus Biosystems IPO soon?
No public IPO plans have been announced for Torus Biosystems.
How can I track Torus Biosystems secondary market activity?
Caplight tracks bids, offers, and trades in Torus Biosystems's shares on secondary markets.